The discovery and impact of the Epstein-Barr virus continue to unfold, with current research study highlighting prospective repurposing of existing drugs to control the virus and prevent involved illness like cancer in clients with weakened immune systems. The Epstein-Barr virus made scientific history as the first virus proven to trigger cancer in human beings. Till now, theres been nothing specific for preventing or treating Epstein-Barr infection associated illness,” says Hess.Reference: “A metabolic reliance of EBV can be targeted to prevent B cell change” 23 May 2024, Science.DOI: 10.1126/ science.adk4898.
The discovery and effect of the Epstein-Barr infection continue to unfold, with current research highlighting possible repurposing of existing drugs to manage the infection and avoid associated illness like cancer in patients with weakened immune systems. Credit: SciTechDaily.comThe Epstein-Barr infection (EBV) can cause a spectrum of illness, consisting of a range of cancers. The Epstein-Barr virus made scientific history as the very first virus shown to trigger cancer in people. Till now, theres been nothing specific for preventing or dealing with Epstein-Barr infection associated disease,” says Hess.Reference: “A metabolic dependency of EBV can be targeted to impede B cell change” 23 May 2024, Science.DOI: 10.1126/ science.adk4898.
